Zevra Therapeutics, Inc. (ZVRA) Operating margin 2019–2025
Zevra Therapeutics, Inc. (ZVRA) operating margin by fiscal year — reported operating income divided by reported revenue.
-59.1%FY2025 · since FY2019: -158.4% → -59.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -59.1% | +309.4 pp |
| FY2024 | -368.5% | -187.8 pp |
| FY2023 | -180.6% | +238.3 pp |
| FY2022 | -418.9% | -445.9 pp |
| FY2021 | 27.0% | +69.2 pp |
| FY2020 | -42.2% | +116.2 pp |
| FY2019 | -158.4% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice